injecting compounded tirzepatide FDA Says Must Exit the Market Compound Tirzepatide

APPROACHES TO PRIMARY CARE Some employers are using alternative approaches to provide primary care options for their workers

Regular communication between primary care providers, endocrinologists, and hepatologists optimizes outcomes for patients with fatty liver disease receiving GLP-1 therapy

Rita Kathawa will review your history, answer your questions, and recommend the right GLP-1 protocol for you

2025;27:iii13742

Ozempic is an FDA-approved glucagon-like peptide-1 (GLP-1) receptor agonist f Type 2 Diabetes (T2D). Its also used as an off-label treatment for obese or overweight adults with at least one weight-related comorbidity. Wegovy is FDA-approved solely for the treatment of chronic weight management in adults with obesity or overweight and one comorbid condition, which may include Type 2 Diabetes or other conditions. Both are meant to be used in conjunction with a low-calorie diet and regular physical activity

#clinicalmedicine #rhabdomyolysis #internalmedicine Regards, Dr